2007Journal of Clinical Internal MedicineRequires access

Comparison of the effects of losartan and amlodipine on plasma leptin and norepinephrine in hypertensive obese patients

Huiying Xu

Open publisher page 0 citations

Abstract

Objective Aim of this study was to compare the effect of losartan and amlodipine on blood pressure (BP),plasma leptin (L) and plasma norepinephrine (NE) in obese hypertensive patients.Methods The radioimmunoassay method was used to determine the level of plasma leptin,the plasma NE levels were determined by high performance liquid chroma-tography (HPLC).Results The levels of plasma leptin was signify-cantly decreased in losartan group as compared to before treating(P0.05),but there was no difference in amlodipine group.The levels of plasma NE was significantly increased in amlodipine group as compared to before treating(P0.01),but there was no difference in losartan group(P0.05).Conclusions These results suggest that losartan might offer an advantage over amlodipine in obese hypertensive patients,since losartan may help to improve obesity-related disorders in addition to lowering Bp.

About this research paper

What this paper is about

Objective Aim of this study was to compare the effect of losartan and amlodipine on blood pressure (BP),plasma leptin (L) and plasma norepinephrine (NE) in obese hypertensive patients.Methods The radioimmunoassay method was used to determine the level of plasma leptin,the plasma NE levels were determined by high performance liquid chroma-tography (HPLC).Results The levels of plasma leptin was signify-cantly decreased in losartan group as compared to before treating(P0.05),but there was no difference in amlodipine group.The levels of plasma NE was significantly increased in amlodipine group as compared to before treating(P0.01),but there was no difference in losartan group(P0.05).Conclusions These results suggest that losartan might offer an advantage over amlodipine in obese hypertensive patients,since losartan may help to improve obesity-related disorders in addition to lowering Bp.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective Aim of this study was to compare the effect of losartan and amlodipine on blood pressure (BP),plasma leptin (L) and plasma norepinephrine (NE) in obese hypertensive patients.Methods The radioimmunoassay method was used to determine the level of plasma leptin,the plasma NE levels were determined by high performance liquid chroma-tography (HPLC).Results The levels of plasma leptin was signify-cantly decreased in losartan group as compared to before treating(P0.05),but there was no difference in amlodipine group.The levels of plasma NE was significantly increased in amlodipine group as compared to before treating(P0.01),but there was no difference in losartan group(P0.05).Conclusions These results suggest that losartan might offer an advantage over amlodipine in obese hypertensive patients,since losartan may help to improve obesity-related disorders in addition to lowering Bp.

Key concepts: Losartan, Amlodipine, Medicine, Internal medicine, Leptin, Endocrinology, Blood pressure, Norepinephrine

Related papers

Back to paper searchBrowse research topicsOriginal source
Comparison of the effects of losartan and amlodipine on plasma leptin and norepinephrine in hypertensive obese patients — Research Paper | ScholarLens